Pixie Dust Technologies, Inc. announced a joint research agreement with Tohoku University School of Medicine (the "University") for the purpose of developing and commercializing certain non-pharmaceutical skin disease treatments using wave control technology.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.48 USD | +0.40% | +1.22% | -64.47% |
13/03 | Pixie Dust Technologies Announces Chief Financial Officer Changes | CI |
26/02 | Pixie Dust Technologies, Inc. Announces Amendment to Loan Agreement | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-64.47% | 3.63Cr | |
-12.80% | 19TCr | |
+1.53% | 17TCr | |
+3.73% | 16TCr | |
+8.06% | 10TCr | |
+35.23% | 8.37TCr | |
+11.51% | 8.21TCr | |
-6.43% | 7.18TCr | |
-17.43% | 5.41TCr | |
-8.68% | 4.35TCr |
- Stock Market
- Equities
- PXDT Stock
- News Pixie Dust Technologies, Inc.
- Pixie Dust Technologies, Inc. Announces Collaborative Research Agreement with Tohoku University School of Medicine